KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Global Medical REIT (GMRE) over the last 14 years, with Q3 2025 value amounting to $17.6 million.

  • Global Medical REIT's Cash from Operations rose 775.36% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.5 million, marking a year-over-year increase of 717.24%. This contributed to the annual value of $70.0 million for FY2024, which is 234.66% up from last year.
  • According to the latest figures from Q3 2025, Global Medical REIT's Cash from Operations is $17.6 million, which was up 775.36% from $22.1 million recorded in Q2 2025.
  • Over the past 5 years, Global Medical REIT's Cash from Operations peaked at $23.5 million during Q2 2022, and registered a low of $12.3 million during Q1 2025.
  • Over the past 5 years, Global Medical REIT's median Cash from Operations value was $17.8 million (recorded in 2021), while the average stood at $17.7 million.
  • As far as peak fluctuations go, Global Medical REIT's Cash from Operations soared by 43962.4% in 2021, and later crashed by 2386.83% in 2023.
  • Quarter analysis of 5 years shows Global Medical REIT's Cash from Operations stood at $17.3 million in 2021, then grew by 5.93% to $18.3 million in 2022, then dropped by 1.0% to $18.1 million in 2023, then rose by 13.23% to $20.5 million in 2024, then fell by 14.41% to $17.6 million in 2025.
  • Its Cash from Operations was $17.6 million in Q3 2025, compared to $22.1 million in Q2 2025 and $12.3 million in Q1 2025.